BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29125487)

  • 1. Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.
    Villamil-Ortiz JG; Barrera-Ocampo A; Arias-Londoño JD; Villegas A; Lopera F; Cardona-Gómez GP
    J Alzheimers Dis; 2018; 61(1):209-219. PubMed ID: 29125487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual task abilities as a possible preclinical marker of Alzheimer's disease in carriers of the E280A presenilin-1 mutation.
    MacPherson SE; Parra MA; Moreno S; Lopera F; Della Sala S
    J Int Neuropsychol Soc; 2012 Mar; 18(2):234-41. PubMed ID: 22133015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.
    Ochoa JF; Alonso JF; Duque JE; Tobón CA; Baena A; Lopera F; Mañanas MA; Hernández AM
    J Alzheimers Dis; 2017; 58(4):1229-1244. PubMed ID: 28550254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.
    Conquer JA; Tierney MC; Zecevic J; Bettger WJ; Fisher RH
    Lipids; 2000 Dec; 35(12):1305-12. PubMed ID: 11201991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.
    Bascoul-Colombo C; Guschina IA; Maskrey BH; Good M; O'Donnell VB; Harwood JL
    Biochim Biophys Acta; 2016 Jun; 1861(6):524-37. PubMed ID: 26968097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
    Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.
    Söderberg M; Edlund C; Kristensson K; Dallner G
    Lipids; 1991 Jun; 26(6):421-5. PubMed ID: 1881238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease.
    Guan Z; Wang Y; Cairns NJ; Lantos PL; Dallner G; Sindelar PJ
    J Neuropathol Exp Neurol; 1999 Jul; 58(7):740-7. PubMed ID: 10411344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.
    Velez-Pardo C; Arellano JI; Cardona-Gomez P; Jimenez Del Rio M; Lopera F; De Felipe J
    Epilepsia; 2004 Jul; 45(7):751-6. PubMed ID: 15230697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modifiers of cognitive decline in PSEN1 E280A Alzheimer's disease.
    Sepulveda-Falla D; Vélez JI; Acosta-Baena N; Baena A; Moreno S; Krasemann S; Lopera F; Mastronardi CA; Arcos-Burgos M
    Alzheimers Dement; 2024 Apr; 20(4):2873-2885. PubMed ID: 38450831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.
    Chatterjee P; Lim WL; Shui G; Gupta VB; James I; Fagan AM; Xiong C; Sohrabi HR; Taddei K; Brown BM; Benzinger T; Masters C; Snowden SG; Wenk MR; Bateman RJ; Morris JC; Martins RN
    J Alzheimers Dis; 2016; 50(3):887-94. PubMed ID: 26836186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex.
    Martín V; Fabelo N; Santpere G; Puig B; Marín R; Ferrer I; Díaz M
    J Alzheimers Dis; 2010; 19(2):489-502. PubMed ID: 20110596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
    Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
    J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
    Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
    Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
    Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
    Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.
    Grimm MO; Grösgen S; Riemenschneider M; Tanila H; Grimm HS; Hartmann T
    J Chromatogr A; 2011 Oct; 1218(42):7713-22. PubMed ID: 21872257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.